Pew Testifies to Congress on Implementation of the Federal Compounding Law

Pew Testifies to Congress on Implementation of the Federal Compounding Law

Elizabeth Jungman, director of public health programs at The Pew Charitable Trusts, testified Jan. 30 before the House of Representatives’ Energy and Commerce Subcommittee on Health at a hearing titled “Examining Implementation of the Compounding Quality Act.”

In her testimony, Jungman conveyed Pew’s strong support for the continued robust implementation and enforcement of the Drug Quality and Security Act (DQSA), and Pew’s firm belief that weakening the DQSA would harm patient safety. She also shared some early findings from a study Pew will publish next month showing that the DQSA has been complemented by improved compounding oversight in the states.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.